Latest News by Industry
PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — Guardant Health Inc. (GH) on Wednesday reported a loss of $107.8 million in its third quarter.
On a per-share basis, the Palo Alto, California-based company said it had a loss of 88 cents. Losses, adjusted for stock option expense and non-recurring costs, came to 45 cents per share.
The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 55 cents per share.
The provider of oncology testing services posted revenue of $191.5 million in the period, also beating Street forecasts. Nine analysts surveyed by Zacks expected $169.9 million.
Guardant Health expects full-year revenue in the range of $720 million to $725 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GH at https://www.zacks.com/ap/GH